Table 3.
Parameter | Variable | AKI at 48h | P value | AKI at 7days | P value |
---|---|---|---|---|---|
Age group (yrs) | 18 – 25 | 8 (29.8%) | 0.883 | 5 (26.3%) | 0.514 |
26 – 45 | 7 (25.9%) | 4 (21.1% | |||
46 – 65 | 9 (33.3%) | 7 (36.8%) | |||
> 65 | 3 (11.1%) | 3 (15.8%) | |||
| |||||
Sex | Male | 24 (88.9%) | 0.003 | 18 (94.7%) | 0.003 |
Female | 3 (11.1) | 1 (5.3%) | |||
| |||||
Comorbids | None | 18 (66.7%) | 0.745 | 12 (63.2%) | 0.669 |
Hypertension | 4 (14.8%) | 3 (15.8%) | |||
Diabetes | 1 (3.7%) | 1 (5.3%) | |||
Others | 3 (11.1%) | 1 (5.3%) | |||
| |||||
Parasitemia (%) | <0.5% | 1 (3.7%) | 0.004 | 1 (5.3%) | 0.046 |
0.5-1.0% | 7 (25.9%) | 5 (26.3%) | |||
1.1-5% | 11 (40.7%) | 7 (36.8%) | |||
5.1-10% | 1 (3.7%) | 1 (5.3%) | |||
>10% | 7 (25.9%) | 5 (26.3%) | |||
| |||||
Hemoglobin (g/dl) | <7.5 | 4 (14.8%) | 0.010 | 2 (10.5%) | 0.017 |
7.7-9 | 3 (11.1%) | 3 (15.8%) | |||
9.1-11 | 3 (11.1%) | 2 (10.5%) | |||
>11 | 17 (63.0%) | 12 (63.2%) | |||
| |||||
Platelets ∗103/mm3 | <25 | 7 (25.9%) | <0.001 | 7 (36.8%) | <0.001 |
25-50 | 6 (22.2%) | 4 (21.1%) | |||
51-100 | 10 (37.0%) | 4 (21.1%) | |||
101-150 | 2 (7.4%) | 2 (10.5%) | |||
>150 | 2 (7.4%) | 2 (10.5%) | |||
| |||||
Urine protein | None | 3 (11.1%) | 0.001 | 2 (10.5%) | <0.001 |
Trace | 2 (7.4%) | 2 (10.5%) | |||
1 – 2 + | 15 (55.6%) | 8 (42.1%) | |||
3 + | 7 (25.9%) | 7 (36.8%) | |||
| |||||
CRP (mg/L) | <4 | 1 (3.7%) | 0.126 | 1 (5.3%) | 0.223 |
4-10 | 2 (7.4%) | 1 (5.3%) | |||
11-50 | 3 (11.1%) | 2 (10.5%) | |||
>50 | 21 (77.8%) | 15 (78.9%) |